- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.01. | Vaso Corporation Announces Executive Leadership Appointments & Names New Vice Chairman to the Board of Directors | 92 | GlobeNewswire (Europe) | PLAINVIEW, N.Y, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leader in human capital, information technology and MedTech, today announced new executive appointments... ► Artikel lesen | |
| 03.01. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 20.12.24 | SRV YHTIOT OYJ: SRV will implement right-of-occupancy housing units for Vaso in Kuloistenniitty, Raisio - the units will have an energy class A rating | 4 | Cision News | ||
| 16.12.24 | Vaso Corporation CEO Reflects on a Year of Growth and Innovation in End-of-Year Letter Setting the Tone for a Promising 2025 | 56 | GlobeNewswire (Europe) | Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 NEWS RELEASE PLAINVIEW, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX:... ► Artikel lesen | |
| VASO Aktie jetzt für 0€ handeln | |||||
| 22.11.24 | Vaso Corp CEO Ma Jun erwirbt Stammaktien im Wert von 26.000 US-Dollar | 1 | Investing.com Deutsch | ||
| 14.11.24 | Vasomedical reports Q3 results | 1 | Seeking Alpha | ||
| 14.11.24 | Vaso Corporation Announces Financial Results for Third Quarter 2024 | 112 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 19.09.24 | Vaso announces termination of business combination with Achari Ventures Holdings Corp. I | 1 | Seeking Alpha | ||
| 19.09.24 | Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I | 126 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I ("Achari") to terminate... ► Artikel lesen | |
| 19.09.24 | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 10.09.24 | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08.24 | Vaso Corporation Announces Date Change for Its Stockholders Meeting | 1 | GlobeNewswire (USA) | ||
| 23.08.24 | Vaso Corp announces pro forma financials amid business combination | 1 | Investing.com | ||
| 23.08.24 | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.08.24 | VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts | 1 | Zacks | ||
| 15.08.24 | Vasomedical reports Q2 results | 1 | Seeking Alpha | ||
| 14.08.24 | VASO Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08.24 | Vaso Corporation Announces Financial Results for Second Quarter 2024 | 107 | GlobeNewswire (Europe) | High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating... ► Artikel lesen | |
| 07.08.24 | Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4 | 1 | GlobeNewswire (USA) | ||
| 15.05.24 | Vaso Corporation Announces Financial Results for First Quarter 2024 | 136 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. "Total revenue for the first... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 20,895 | -0,85 % | Bayer, DAX, Novo Nordisk, Siemens Energy, Verbio, Vonovia - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| ASTRAZENECA | 131,75 | +0,34 % | JEFFERIES stuft ASTRAZENECA auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Astrazeneca von 11400 auf 10900 Pence gesenkt, aber die Einstufung auf "Hold" belassen. Die Briten könnten zwar die Umsatzerwartungen... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 8,440 | -0,54 % | EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Sees Large Increase in Short Interest | ||
| IONIS PHARMACEUTICALS | 32,900 | -0,54 % | Ionis stock rises on FDA, EMA nod for SMA drug dose increase | ||
| CSPC PHARMA | 0,530 | -2,36 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURNS | ||
| ACADIA PHARMACEUTICALS | 18,100 | -1,25 % | Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome | -- Filing marks company's first Marketing Authorization Application in Europe
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 0,983 | +3,58 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia | - REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 311,60 | -4,62 % | AKTIONÄR-Hot-Stock Madrigal: Erneute Übernahmegerüchte - Aktie mit Kurssprung | Am späten Freitagabend hat die Aktie des Biotech-Unternehmens Madrigal einen starken Kursanstieg verzeichnet. Erneut halten sich Gerüchte um die Gesellschaft, die mit Rezdiffra (Resmetirom) die erste... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 21,620 | +0,09 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE in Japan | CORAL GABLES, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,086 | -21,82 % | ENZON PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| OPUS GENETICS | 1,056 | -4,00 % | Opus Genetics, Inc. - 8-K, Current Report | ||
| CHUGAI PHARMACEUTICAL | 38,380 | -1,46 % | Dividendenbekanntmachungen (27.12.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 3 JPY 0,0182 EUR AGC INC JP3112000009 105 JPY 0,6373 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R) | Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,160 | +5,26 % | Viracta Therapeutics, Inc. - 8-K, Current Report | ||
| SAVARA | 2,660 | -3,62 % | Savara Inc - 8-K, Current Report |
VASO CORPORATION gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.
